UMIN-ICDS Clinical Trial

Unique ID issued by UMIN UMIN000061942
Receipt number R000070874
Scientific Title Acute Effects of Various Types of Standing-Sitting Exercises on Postprandial Glucose Levels in Young Adults with Postprandial Glucose Spikes: A Randomized Controlled Trial
Date of disclosure of the study information 2026/06/17
Last modified on 2026/06/17 12:28:21

* This page includes information on clinical trials registered in UMIN clinical trial registed system.
* We don't aim to advertise certain products or treatments


Basic information

Public title

The Effects of Various Types of Standing-Sitting Exercises on Postprandial Blood Glucose Levels

Acronym

A Comparison of Various Types of Standing-Sitting Exercises

Scientific Title

Acute Effects of Various Types of Standing-Sitting Exercises on Postprandial Glucose Levels in Young Adults with Postprandial Glucose Spikes: A Randomized Controlled Trial

Scientific Title:Acronym

Acute Effects of Various Types of Standing-Sitting Exercises on Postprandial Hyperglycemia

Region

Japan


Condition

Condition

Postprandial glucose spike

Classification by specialty

Endocrinology and Metabolism Adult

Classification by malignancy

Others

Genomic information

NO


Objectives

Narrative objectives1

To clarify the effects of various types of standing-to-sitting exercises on postprandial blood glucose levels in young adults with blood glucose spikes, compared to walking

Basic objectives2

Efficacy

Basic objectives -Others


Trial characteristics_1

Confirmatory

Trial characteristics_2


Developmental phase



Assessment

Primary outcomes

Incremental area under the blood glucose curve up to 120 minutes after glucose loading

Key secondary outcomes

Peak blood glucose level after glucose loading, lactate levels after exercise, average heart rate during exercise, perceived exertion, and blood pressure before and after exercise


Base

Study type

Interventional


Study design

Basic design

Cross-over

Randomization

Randomized

Randomization unit

Individual

Blinding

Open -no one is blinded

Control

No treatment

Stratification


Dynamic allocation


Institution consideration


Blocking


Concealment



Intervention

No. of arms

6

Purpose of intervention

Treatment

Type of intervention

Other

Interventions/Control_1

30-second standing and sitting exercises after a meal

Interventions/Control_2

5-minute standing and sitting exercises after a meal

Interventions/Control_3

5-minute interval standing and sitting exercises after a meal

Interventions/Control_4

30-minute standing and sitting exercises after a meal

Interventions/Control_5

30-minute walking after a meal

Interventions/Control_6

Sitting rest after a meal

Interventions/Control_7


Interventions/Control_8


Interventions/Control_9


Interventions/Control_10



Eligibility

Age-lower limit

18 years-old <=

Age-upper limit

30 years-old >

Gender

Male

Key inclusion criteria

Blood glucose level of 140 mg/dL or higher 60 minutes after a glucose load

Key exclusion criteria

Diabetes and other conditions that limit physical activity

Target sample size

13


Research contact person

Name of lead principal investigator

1st name Kumiko
Middle name
Last name Ono

Organization

Kobe University

Division name

Life and Medical Sciences Area, Health Sciences Discipline

Zip code

654-0142

Address

7-10-2 Tomogaoka, Suma, Kobe, 654-0142, JAPAN

TEL

078-796-4515

Email

onoku@tiger.kobe-u.ac.jp


Public contact

Name of contact person

1st name Yuto
Middle name
Last name Nakayama

Organization

Kobe University

Division name

Graduate School of Medicine

Zip code

654-0142

Address

7-10-2 Tomogaoka, Suma, Kobe, 654-0142, JAPAN

TEL

078-796-4515

Homepage URL


Email

ynakayama@bear.kobe-u.ac.jp


Sponsor or person

Institute

Kobe University

Institute

Department

Personal name



Funding Source

Organization

Japan Science and Technology Agency

Organization

Division

Category of Funding Organization

Japanese Governmental office

Nationality of Funding Organization

Japan


Other related organizations

Co-sponsor


Name of secondary funder(s)



IRB Contact (For public release)

Organization

Ethics Committee of the Graduate School of Medicine, Kobe University (Myoudani Campus)

Address

7-10-2 Tomogaoka, Suma, Kobe, 654-0142, JAPAN

Tel

078-796-4502

Email

syomu2@ams.kobe-u.ac.jp


Secondary IDs

Secondary IDs

NO

Study ID_1


Org. issuing International ID_1


Study ID_2


Org. issuing International ID_2


IND to MHLW



Institutions

Institutions

神戸大学大学院医学系研究科(名谷キャンパス)


Other administrative information

Date of disclosure of the study information

2026 Year 06 Month 17 Day


Related information

URL releasing protocol


Publication of results

Unpublished


Result

URL related to results and publications


Number of participants that the trial has enrolled


Results


Results date posted


Results Delayed


Results Delay Reason


Date of the first journal publication of results


Baseline Characteristics


Participant flow


Adverse events


Outcome measures


Plan to share IPD


IPD sharing Plan description



Progress

Recruitment status

Preinitiation

Date of protocol fixation

2026 Year 06 Month 01 Day

Date of IRB


Anticipated trial start date

2026 Year 07 Month 01 Day

Last follow-up date

2028 Year 03 Month 31 Day

Date of closure to data entry


Date trial data considered complete


Date analysis concluded



Other

Other related information



Management information

Registered date

2026 Year 06 Month 17 Day

Last modified on

2026 Year 06 Month 17 Day



Link to view the page

Value
https://center6.umin.ac.jp/cgi-open-bin/icdr_e/ctr_view.cgi?recptno=R000070874